Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 8,100.00
-60.00 (-0.74%)
May 21, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 45.12 billion as of May 20, 2026. Its market cap has decreased by -36.15% in one year.
Market Cap
45.12B
Enterprise Value
30.73B
Revenue
30.41B
Ranking
n/a
PE Ratio
8.53
Stock Price
8,100.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 45.12B, a decrease of -84.31%. That is a compound annual growth rate of -65.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 45.12B | -17.16% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.16T |
| Celltrion | 38.40T |
| ALTEOGEN | 19.13T |
| Samsung Epis Holdings | 12.35T |
| HASS Corp. | 59.60B |
| ORIENT BIO | 57.27B |
| MYUNGMOON Pharm co.,Ltd | 54.66B |
| EOFLOW | 51.11B |